Bokf Na Has $6.77 Million Stock Position in Colgate-Palmolive Company $CL

Key Points

• Bokf Na reduced its position in Colgate‑Palmolive by 14.5% in Q4, selling 14,533 shares and ending the period with 85,631 shares valued at about $6.77 million.
• Colgate reported quarterly EPS of $0.97 (vs. $0.94 consensus) and revenue of $5.32 billion, up 8.4% year‑over‑year, and raised its quarterly dividend to $0.53 (a 2.4% yield).
• Insiders have sold 70,989 shares (~$6.76M) over the past three months while institutional investors own 80.41% of the stock; analysts give a consensus rating of Moderate Buy with a $95.88 target.

Bokf Na decreased its position in Colgate-Palmolive Company (NYSE:CL - Free Report) by 14.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 85,631 shares of the company's stock after selling 14,533 shares during the period. Bokf Na's holdings in Colgate-Palmolive were worth $6,767,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in CL. Brighton Jones LLC grew its holdings in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after buying an additional 450 shares during the period. Woodline Partners LP lifted its position in Colgate-Palmolive by 76.3% in the 1st quarter. Woodline Partners LP now owns 46,361 shares of the company's stock valued at $4,344,000 after acquiring an additional 20,062 shares in the last quarter. Schnieders Capital Management LLC. lifted its position in Colgate-Palmolive by 2.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 12,494 shares of the company's stock valued at $1,136,000 after acquiring an additional 245 shares in the last quarter. Nebula Research & Development LLC lifted its position in Colgate-Palmolive by 165.5% in the 2nd quarter. Nebula Research & Development LLC now owns 10,326 shares of the company's stock valued at $939,000 after acquiring an additional 6,437 shares in the last quarter. Finally, Sei Investments Co. lifted its position in Colgate-Palmolive by 21.7% in the 2nd quarter. Sei Investments Co. now owns 657,093 shares of the company's stock valued at $59,732,000 after acquiring an additional 116,968 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 2.2%

Shares of NYSE:CL opened at $88.21 on Thursday. The company's 50-day moving average price is $87.60 and its two-hundred day moving average price is $84.28. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.29. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The stock has a market capitalization of $70.77 billion, a PE ratio of 34.32, a price-to-earnings-growth ratio of 4.47 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.22 billion. During the same period in the previous year, the firm posted $0.91 EPS. The company's revenue for the quarter was up 8.4% on a year-over-year basis. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.83 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be given a dividend of $0.53 per share. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive's payout ratio is presently 82.49%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Weiss Ratings raised shares of Colgate-Palmolive from a "hold (c)" rating to a "hold (c+)" rating in a research report on Monday. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $102.00 price objective on shares of Colgate-Palmolive in a research report on Monday. Barclays boosted their price objective on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an "equal weight" rating in a research report on Tuesday. Rothschild & Co Redburn set a $100.00 price objective on shares of Colgate-Palmolive and gave the company a "buy" rating in a research report on Tuesday, April 21st. Finally, Citigroup boosted their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a research report on Monday, February 2nd. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $95.88.

Insider Activity

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the business's stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares of the company's stock, valued at $1,663,041.25. The trade was a 54.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of the company's stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares in the company, valued at approximately $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 70,989 shares of company stock worth $6,756,713 over the last three months. Insiders own 0.43% of the company's stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.